Researchers from University of California San Diego and Stanford have developed an AI-driven, non-invasive method to monitor heart muscle cell activity.
Traditional techniques that capture electrical signals from heart muscle cells often involve invasive procedures and can damage cells.
The new method uses an array of nanoscale electrodes to record external electrical signals, which can then be used to reconstruct internal signals through machine learning algorithms.
This allows for a complete overview of cellular activity, without risking cellular integrity.
The technique has potential implications for drug development, by allowing scientists to perform screenings on human-derived heart cells.
The AI-driven method could help reduce the reliance on animal models, speed up drug discovery, and allow for tailored treatment of diseases.
The research is not limited to cardiology either and has potential for other cell types.
Researchers hope to refine the AI models to improve intracellular signal reconstruction, and potentially offer predictive models for how drugs affect cardiac tissues.
The research has been published in Nature Communications.
This innovation could dramatically reduce the time and costs associated with drug development.